“…These desirable biological properties, together with the unique structure (“all- cis ” relative configuration of the three substituents at the stereogenic centers around the pyrrolidine ring) of (+)-preussin, quickly made it a popular target for synthesis: the first total synthesis of (+)-preussin was reported in 1991 (starting from d -glucose), and to date, more than twenty five different routes to (+)-preussin have been developed. A large number of these rely on derivatization of readily available chiral pool materials: elaboration of l -phenylalanine facilitated the second synthesis of (+)-preussin that was reported, and this material (or derivatives thereof) has proven to be the most popular starting material by far in subsequent syntheses, − although (in chronological order) d -phenylalanine, d -arabinose, l -aspartic acid, l -pyroglutaminol, , l -serine, , and ( S )-malic acid , (or derivatives thereof) have also been employed as the sources of chirality. Other de novo asymmetric syntheses have been developed, − along with one formal synthesis of (+)-preussin − and two syntheses of (−)-preussin. , Moreover, the synthesis of all eight possible stereoisomers (using an enantiopure phenylalanine derivative as the starting material, proceeding via two nonselective reactions and chromatographic separation) has been reported, − as well as one synthesis of (±)-preussin. , The truncated analogue (+)-preussin B, (2 S ,3 S ,5 R )- N (1)-methyl-2-benzyl-5-(1′-heptyl)pyrrolidin-3-ol (Figure ), was isolated [along with (+)-preussin] in 2014 from Simplicillium lanosoniveum TAMA 173 and was shown to exhibit weak antifungal activity .…”